177 related articles for article (PubMed ID: 31836255)
1. Human papillomavirus vaccination coverage, policies, and practical implementation across Europe.
Nguyen-Huu NH; Thilly N; Derrough T; Sdona E; Claudot F; Pulcini C; Agrinier N;
Vaccine; 2020 Feb; 38(6):1315-1331. PubMed ID: 31836255
[TBL] [Abstract][Full Text] [Related]
2. The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018-2019).
Bonanni P; Faivre P; Lopalco PL; Joura EA; Bergroth T; Varga S; Gemayel N; Drury R
Expert Rev Vaccines; 2020 Nov; 19(11):1073-1083. PubMed ID: 33267673
[No Abstract] [Full Text] [Related]
3. Exploring variation in human papillomavirus vaccination uptake in Switzerland: a multilevel spatial analysis of a national vaccination coverage survey.
Riesen M; Konstantinoudis G; Lang P; Low N; Hatz C; Maeusezahl M; Spaar A; Bühlmann M; Spycher BD; Althaus CL
BMJ Open; 2018 May; 8(5):e021006. PubMed ID: 29773702
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
[TBL] [Abstract][Full Text] [Related]
5. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
[TBL] [Abstract][Full Text] [Related]
6. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
Abdullahi LH; Hussey GD; Wiysonge CS; Kagina BM
S Afr Med J; 2020 May; 110(6):525-531. PubMed ID: 32880566
[TBL] [Abstract][Full Text] [Related]
7. Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability - HPV vaccine demonstration program, Cambodia - 2017.
Garon J; Wuddhika IV; Sreenivasan N; Wannemuehler K; Vutthikol Y; Chhorvann C; Loharikar A
Vaccine; 2019 Feb; 37(9):1202-1208. PubMed ID: 30686637
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide.
Owsianka B; Gańczak M
Przegl Epidemiol; 2015; 69(1):53-8, 151-5. PubMed ID: 25862448
[TBL] [Abstract][Full Text] [Related]
9. Successful implementation and results of an HPV vaccination program in Geneva Canton, Switzerland.
Jeannot E; Petignat P; Sudre P
Public Health Rep; 2015; 130(3):202-6. PubMed ID: 25931623
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus vaccination coverage in Luxembourg - Implications of lowering and restricting target age groups.
Latsuzbaia A; Arbyn M; Weyers S; Mossong J
Vaccine; 2018 Apr; 36(18):2411-2416. PubMed ID: 29602702
[TBL] [Abstract][Full Text] [Related]
11. Strengthening the Effectiveness of National, State, and Local Efforts to Improve HPV Vaccination Coverage in the United States: Recommendations From the National Vaccine Advisory Committee.
Approved by the National Vaccine Advisory Committee on June 25, 2018
Public Health Rep; 2018; 133(5):543-550. PubMed ID: 30091942
[TBL] [Abstract][Full Text] [Related]
12. Policy and socio-cultural differences between cantons in Switzerland with high and low adolescent vaccination coverage for hepatitis B and HPV.
Masserey Spicher V; Weiss MG
Vaccine; 2019 Dec; 37(52):7539-7546. PubMed ID: 31630937
[TBL] [Abstract][Full Text] [Related]
13. Challenges to optimising uptake and delivery of a HPV vaccination programme for men who have sex with men.
Forster AS; Gilson R
Hum Vaccin Immunother; 2019; 15(7-8):1541-1543. PubMed ID: 30570380
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus vaccination acceptance and hesitancy in South Africa: Research and policy agenda.
Ngcobo NJ; Burnett RJ; Cooper S; Wiysonge CS
S Afr Med J; 2018 Dec; 109(1):13-15. PubMed ID: 30606297
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
16. Social determinants of community-level human papillomavirus vaccination coverage in aschool-based vaccination programme.
Jean S; Elshafei M; Buttenheim A
Sex Transm Infect; 2018 Jun; 94(4):248-253. PubMed ID: 29330310
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus vaccine introduction--the first five years.
Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
[TBL] [Abstract][Full Text] [Related]
18. Safety of HPV vaccines in the age of nonavalent vaccination.
Quattrone F; Canale A; Filippetti E; Tulipani A; Porretta A; Lopalco PL
Minerva Pediatr; 2018 Feb; 70(1):59-66. PubMed ID: 29363293
[TBL] [Abstract][Full Text] [Related]
19. Parental attitudes towards male human papillomavirus vaccination: a pan-European cross-sectional survey.
Lee Mortensen G; Adam M; Idtaleb L
BMC Public Health; 2015 Jul; 15():624. PubMed ID: 26152138
[TBL] [Abstract][Full Text] [Related]
20. Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program.
Faisal-Cury A; Levy RB; Tourinho MF; Grangeiro A; Eluf-Neto J
BMC Public Health; 2020 Apr; 20(1):458. PubMed ID: 32252705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
